J&J’s DePuy Ortho faces $247m ruling in Pinnacle bellwether trial

This article was originally published here
Share

gavel

A Dallas federal jury this week ruled that Johnson & Johnson (NYSE:JNJ) and its DePuy Orthopaedics must pay $247 million to six patients claiming to be injured by its Pinnacle metal-on-metal hip implants, according to a Reuters report.

The jury ruled that the controversial metal-on-metal hip implants were defectively designed and that patients did not receive appropriate warning about the risks associated with them, according to the report.

The six plaintiffs and patients in the case claim that after implantation, the devices led to injuries including tissue death, bone erosion and other negative health effects, according to Reuters.

Johnson & Johnson said that it would immediately begin the appeal process in the case, according to the report, with a DePuy spokesperson saying the company is “committed to the long-term defense of the allegations in these lawsuits.”

In the case, plaintiffs said that the companies falsely promoted the device with claims that it would last longer than more basic implants which featured plastic or ceramic materials.

The verdict is the fourth test trial in Dallas federal court over the metal-on-metal Pinnacle hips, with over 9,000 cases pending.

In December, a federal jury in Dallas ordered J&J and DePuy Orthopedics to pay more than $1 billion to 6 plaintiffs claiming to be injured by its Pinnacle metal-on-metal hip implants, according to the plaintiffs lawyers.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply